SEC Form 4 · accession 0001654954-17-011655
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Janet Dillione
Director
Period of report
Dec 12, 2017
Accepted (ET)
Dec 14, 2017 · 4:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 12, 2017 | P | 52,083 | $0.48 | A | 92,052 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom StockF2 | $0.00 | holding | — | — | — | — | — | Common Stock | 15,625 | 15,625 | D |
| Phantom StockF2 | $0.00 | holding | — | — | — | — | — | Common Stock | 20,833 | 20,833 | D |
| Stock Option (Right to Buy Common Stock)F3 | $2.24 | holding | — | — | — | — | Feb 21, 2027 | Common Stock | 40,000 | 40,000 | D |
| Restricted Stock UnitsF4 | — | holding | — | — | — | — | — | Common Stock | 15,357 | 15,357 | D |
| Phantom StockF2 | — | holding | — | — | — | — | — | Common Stock | 3,472 | 3,472 | D |
| Phantom StockF2 | — | holding | — | — | — | — | — | Common Stock | 4,143 | 4,143 | D |
| Stock Option (Right to Buy Common Stock)F5 | $3.03 | holding | — | — | — | — | Aug 11, 2025 | Common Stock | 50,000 | 50,000 | D |
| Phantom StockF2 | — | holding | — | — | — | — | — | Common Stock | 1,415 | 1,415 | D |
| Stock Option (Right to Buy Common Stock)F6 | $1.91 | holding | — | — | — | — | Feb 21, 2026 | Common Stock | 95,000 | 95,000 | D |
| Phantom StockF2 | — | holding | — | — | — | — | — | Common Stock | 3,831 | 3,831 | D |
| Phantom StockF2 | — | holding | — | — | — | — | — | Common Stock | 2,767 | 2,767 | D |
| Phantom StockF2 | — | holding | — | — | — | — | — | Common Stock | 4,335 | 4,335 | D |
| Phantom StockF2 | — | holding | — | — | — | — | — | Common Stock | 15,306 | 15,306 | D |
Explanation of responses
- F1Purchase was contracted on November 17, 2017, but not closed until December 12, 2017.
- F2Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
- F3These options were granted on 2/21/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F4These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F5These options were granted on 8/12/2015. The options vest as follows: 1/3 on 8/12/2015, 1/3 on 8/12/2016, and 1/3 on 8/12/2017.
- F6These options were granted on 2/21/2016. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.